Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
Conditions
- Skin Squamous Cell Carcinoma
- Appendix Adenocarcinoma
- Rare Lesion
- Locally Advanced Malignant Neoplasm
- Locally Advanced Skin Squamous Cell Carcinoma
- Metastatic Malignant Neoplasm
- Metastatic Skin Squamous Cell Carcinoma
- Metastatic Small Intestinal Adenocarcinoma
- Rare Neoplastic Syndrome
- Refractory Malignant Neoplasm
- Stage IV Small Intestinal Adenocarcinoma AJCC v8
- Unresectable Malignant Neoplasm
Interventions
- DRUG: Atezolizumab
- DRUG: Cobimetinib
Sponsor
M.D. Anderson Cancer Center
Collaborators